Sort
15,273 grants matching “antimicrobial resistance”
Antimicrobial peptides as models for the evolution of gene duplication
$243,669Robert L Unckless · University Of Kansas Lawrence · R00 · FY2018 · GM
Rapid Simple Antimicrobial Determination and POC Diagnostic for Gonorrhea
$243,652Christi Parham · Lynntech, Inc. · R43 · FY2019 · AI
Development of Q203 (Telacebec) for the Treatment of Tuberculosis and Related Mycobacterial Infections
$243,622Edward Wu · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
Linking Gene Expression Profiles to Cell Fate in Clostridioides difficile Using Time-Lapse Microscopy
$243,600Aimee Shen · Tufts University Boston · R21 · FY2022 · AI
Biology of Infectious Diseases Training Program
$243,467Henry F Chambers · University Of California, San Francisco · T32 · FY2009 · AI
A novel, two-armed autotherapy for mucosal infectious diseases
$243,453Mark C Herzberg · University Of Minnesota · R21 · FY2021 · DE
Whole Genome Sequencing of N. gonorrhoeae from Non-Culture Based Clinical Specimens to Surveil for Emerging Resistance
$243,361Kyle Jeanne Popovich · Rush University Medical Center · R21 · FY2024 · AI
Spin-Labeled Peptide Antibiotics
$243,361Jimmy Feix · Medical College Of Wisconsin · R01 · FY2006 · GM
Vaccine Treatment and Evaluation Units: Phase IV Trial to Evaluate Antimicrobial Therapy of Community Acquired Pneumonia in Children - VTEU
$243,329David Bernstein · Cincinnati Childrens Hosp Med Ctr · N01 · FY2017 · AI
Design of C. parvum and T. gondii DHFR-TS Inhibitors
$243,320Dartmouth College · R01 · FY2003 · GM
Design of C. parvum and T. gondii DHFR-TS Inhibitors
$243,320Dartmouth College · R01 · FY2004 · GM
Role of PA4878 in biofilm antimicrobial resistance
$243,308Karin Sauer · State University Of Ny,Binghamton · R01 · FY2013 · AI
APPROACHES FOR OVERPRODUCTION OF POLYKETIDE ANTIMICRO.
$243,264Kosan Biosciences, Inc. · R43 · FY2000 · AI
The BLAAST Trial: Bangladesh Lung Auscultation AI for Antibiotic Stewardship Randomized Controlled Trial
$243,218Eric Douglass McCollum · Johns Hopkins University · R01 · FY2025 · HD
Chemistry and Biology of Bacterial Sulfonucleotide Reductases
$243,125Kate Suzanne Carroll · Scripps Florida · R01 · FY2010 · GM
Impact of regulatory cross-talk on the pathophysiology of emergent acapsular group A streptococcus
$243,000Samuel A Shelburne · University Of Tx Md Anderson Can Ctr · R21 · FY2021 · AI
Mediator regulation of transporters in fluconazole resistant C. albicans mutants
$243,000Lawrence Christopher Myers · Dartmouth College · R21 · FY2014 · AI
Towards a new regimen to treat mycobacterial infection in cystic fibrosis patients
$243,000Gyanu Lamichhane · Johns Hopkins University · R21 · FY2017 · AI
Single-cell characterization of antibiotic-induced heteroresistance
$243,000Saeed F Tavazoie · Columbia University Health Sciences · R21 · FY2022 · AI
Task B10: Synthesis of building blocks for novel sugar-derived antibiotics
$242,862Bruce Blough · Research Triangle Institute · N01 · FY2020 · AI
Bacterial Evasion of Innate Defenses at the Ocular Surface
$242,747Daria N Van Tyne · University Of Pittsburgh At Pittsburgh · R00 · FY2019 · EY
Antimicrobial Resistance and Therapeutic Discovery Training Program
$242,747William Maurice Shafer · Emory University · T32 · FY2020 · AI
Molecular Analysis of Microbial Pathogens
$242,711Ralph R Isberg · Tufts University Boston · T32 · FY2022 · AI
Quantitative analysis of the evolving genotype-to-phenotype map
$242,662Daniel Jarosz · Stanford University · R00 · FY2014 · GM
Evaluation of a microbiota-sparing therapeutic concept for periodontal disease, involving removal of pathogenic Porphyromonas and Fusobacterium
$242,625Julian G Hurdle · Texas A&M University Health Science Ctr · R21 · FY2024 · DE